ALLERGY THERAPEUTICS PLC

Regulatory Filings • Dec 16, 2014

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 9140Z

Allergy Therapeutics PLC

16 December 2014

16 December 2014

Allergy Therapeutics plc

("Allergy Therapeutics" or the "Company")

Change of Adviser

Allergy Therapeutics plc, the fully integrated specialty pharmaceutical company specialising in allergy vaccines, announces the appointment, with immediate effect, of Panmure Gordon (UK) Limited as its Nominated Adviser and Broker.

-Ends-

For further information

Allergy Therapeutics	+44 (0) 1903 845 820
Manuel Llobet, Chief Executive Officer
Ian Postlethwaite Finance Director
Panmure Gordon	+44 (0) 20 7886 2500
Freddy Crossley / Duncan Monteith, Corporate Finance
Tom Salvesen, Corporate Broking
FTI Consulting	+44 (0) 20 3727 1000
Simon Conway
Victoria Foster Mitchell

About Allergy Therapeutics

Allergy Therapeutics is a specialty pharmaceutical company focused on allergy vaccination.  Ithas a growing business achieving revenue in thelast financial yearof £42 million mainly in Europe through its own sales and marketing infrastructure and further afield through distributors.  The Company is expanding its infrastructure into theEmerging markets.

This information is provided by RNS

The company news service from the London Stock Exchange

END

APPKMMMZZVZGDZM